Non-oral dopaminergic therapies for Parkinson’s disease: current treatments and the future

Dysfunction of the gastrointestinal tract has now been recognized to affect all stages of Parkinson’s disease (PD). The consequences lead to problems with absorption of oral medication, erratic treatment response, as well as silent aspiration, which is one of the key risk factors in developing pneum...

Descripción completa

Detalles Bibliográficos
Autores principales: Ray Chaudhuri, K, Qamar, Mubasher A, Rajah, Thadshani, Loehrer, Philipp, Sauerbier, Anna, Odin, Per, Jenner, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516582/
https://www.ncbi.nlm.nih.gov/pubmed/28725704
http://dx.doi.org/10.1038/npjparkd.2016.23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516582/
https://www.ncbi.nlm.nih.gov/pubmed/28725704
http://dx.doi.org/10.1038/npjparkd.2016.23

Ejemplares similares